BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38300678)

  • 21. [Amiodarone and thyroid dysfunction].
    Rizzo LF; Bruno OD
    Medicina (B Aires); 2012; 72(1):63-74. PubMed ID: 22257461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
    Irimie A; Piciu D
    Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of amiodarone on the thyroid function and safety of the therapy--what's new].
    Hen K; Czarnywojtek A; Stangierski A; Warmuz-Stangierska I; Zdanowska J; Florek E; Ruchała M
    Przegl Lek; 2012; 69(10):1135-9. PubMed ID: 23421109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amiodarone and thyroid].
    Maby-Mottet V; Ollo D; Meyer P
    Rev Med Suisse; 2012 Nov; 8(362):2175-6, 2178-80. PubMed ID: 23240319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of amiodarone therapy on thyroid function.
    Cohen-Lehman J; Dahl P; Danzi S; Klein I
    Nat Rev Endocrinol; 2010 Jan; 6(1):34-41. PubMed ID: 19935743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMIODARONE AND THYROID DYSFUNCTION.
    Medić F; Bakula M; Alfirević M; Bakula M; Mucić K; Marić N
    Acta Clin Croat; 2022 Aug; 61(2):327-341. PubMed ID: 36818930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
    Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
    Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
    Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone-Induced Thyroid Dysfunction: A Clinical Update.
    Elnaggar MN; Jbeili K; Nik-Hussin N; Kozhippally M; Pappachan JM
    Exp Clin Endocrinol Diabetes; 2018 Jun; 126(6):333-341. PubMed ID: 29558786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Hofmann A; Nawara C; Ofluoglu S; Holzmannhofer J; Strohmer B; Pirich C
    Wien Klin Wochenschr; 2008; 120(15-16):493-8. PubMed ID: 18820854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amiodarone-induced thyroid gland dysfunctions].
    Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction].
    Serdiuk SE; Bakalov SA; Soboleva VA; Golitsin SP; Molashenko NV; Platonova NM; Sviridenko NIu
    Kardiologiia; 2004; 44(10):32-8. PubMed ID: 15477787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Amiodarone treatment and thyroid disorders].
    Łacka K; Fraczek MM
    Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzofuran derivatives and the thyroid.
    Han TS; Williams GR; Vanderpump MP
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):2-13. PubMed ID: 18727707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drugs affecting thyroid--part II].
    Kucharczyk P; Michałkiewicz D; Kucharczyk A
    Pol Merkur Lekarski; 2006 Oct; 21(124):367-71. PubMed ID: 17205780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis].
    Ermolaeva AS; Fadeev VV
    Probl Endokrinol (Mosk); 2024 Jan; 69(6):17-27. PubMed ID: 38311991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Challenges in the management of amiodarone-induced thyrotoxicosis].
    Tauveron I; Batisse-Lignier M; Maqdasy S
    Presse Med; 2018 Sep; 47(9):746-756. PubMed ID: 30274916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants and outcome of amiodarone-associated thyroid dysfunction.
    Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.